On the recordSeptember 19, 2016
We cannot take that out of the equation. That should drive the discussion we have.
Source
congress.govWe cannot take that out of the equation. That should drive the discussion we have.
Senator Burr emphasizes the importance of patient impact in regulatory discussions.
Share
More from Richard Burr
I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.
I always like to bring things back to the present because I have a tremendous amount of respect for all four of you.
What does it mean for a small company when FDA misses these goals, and what does it mean to patients?
We have the tools, tests, and vaccinations, therefore, there is no longer a public health reason to bar people from entering this country.